Print

BioMarin Pharmaceutical Inc. (BMRN) Announces Third Quarter 2012 Financial Results  
10/26/2012 6:45:50 AM

SAN RAFAEL, Calif., Oct. 25, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced financial results for the third quarter of 2012. GAAP net loss was $5.4 million ($0.04 per share) for the third quarter of 2012, compared to GAAP net loss of $17.7 million ($0.16 per share) for the third quarter of 2011. Non-GAAP adjusted EBITDA was $11.1 million for the third quarter of 2012, compared to non-GAAP adjusted EBITDA of $4.3 million for the third quarter of 2011. The reduced GAAP net loss and the increased non-GAAP adjusted EBITDA for the third quarter of 2012 compared to the third quarter of 2011 was primarily due to increased net product revenue partially offset by a smaller increase in research and development expenses.
//-->